SCHEMBL18607288

SCHEMBL18607288

O=C1CCCCCCCCCc2ccccc21

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 7/20 0.91
MAOB P27338 6/20 0.91
CYP2A6 P11509 1/20 0.91
CES1 P23141 2/20 0.56
TSHR P16473 1/20 0.55
HPGD P15428 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
GRM5 P41594 1/20 0.49
PRKCI P41743 1/20 0.48
PDPK1 O15530 1/20 0.47
PARP1 P09874 1/20 0.47
PARP10 Q53GL7 1/20 0.47
PARP11 Q9NR21 1/20 0.47
BCHE P06276 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPT P10636 1/20 0.46
MIF P14174 1/20 0.46
NOS3 P29474 1/20 0.44
HSD17B1 P14061 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29766301 1.00 MAOA (0.91) MAOAMAOBCYP2A6CES1TSHR
SCHEMBL163580 1.00 MAOA (0.91) MAOAMAOBCYP2A6CES1TSHR
SCHEMBL4874556 1.00 MAOA (0.91) MAOAMAOBCYP2A6CES1TSHR
SCHEMBL4573854 1.00 MAOA (0.91) MAOAMAOBCYP2A6CES1TSHR
SCHEMBL20445627 1.00 MAOA (0.91) MAOAMAOBCYP2A6CES1TSHR
SCHEMBL18716863 1.00 MAOA (0.91) MAOAMAOBCYP2A6CES1TSHR
Ammonia Solution, Strong SCHEMBL28684723 0.98 MAOA (0.87) MAOAMAOBCYP2A6CES1TSHR
SCHEMBL10456794 0.96 MAOA (0.91) MAOAMAOBCYP2A6CES1TSHR
SCHEMBL44545 0.95 MAOA (1.00) MAOAMAOBCYP2A6CES1TSHR
SCHEMBL29351871 0.95 MAOA (1.00) MAOAMAOBCYP2A6CES1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170066737-A1 CYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170066737-A1 CYCLIC COMPOUNDS TLR4, TLR3, TLR1 MAOA 4696/4885MAOB 4257/4885CYP2A6 3910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.